AFB C/S (DJ Stent for Mycobacterium Tuberculosis) at Chughtai Lab

Understanding the AFB C/S (DJ Stent for Mycobacterium Tuberculosis) at Chughtai Lab

The Acid-Fast Bacilli Culture and Sensitivity (AFB C/S) test on a retrieved Double-J (DJ) ureteral stent is a highly specialized, clinically critical diagnostic investigation. Offered by Chughtai Lab, Pakistan’s premier diagnostic network, this test is specifically designed to detect Mycobacterium tuberculosis infections within the genitourinary tract. Genitourinary tuberculosis (GUTB) is a severe, often insidious manifestation of extrapulmonary tuberculosis. Because the clinical presentation of GUTB frequently mimics other chronic urological conditions, obtaining a definitive microbiological diagnosis is paramount for preventing irreversible renal damage and systemic complications.

A Double-J (DJ) stent is a flexible, synthetic tube placed temporarily within the ureter to maintain patency, facilitate urine flow from the kidney to the bladder, and bypass obstructions caused by strictures, calculi, or inflammatory processes. In patients suspected of having urogenital tuberculosis, these indwelling devices serve as an exceptional substrate for diagnostic sampling. Over time, bacteria adhere to the synthetic biomaterial of the stent, forming a complex, protective biofilm. Culturing the biofilm retrieved from a removed DJ stent provides a highly concentrated specimen of the offending pathogen. This significantly increases the diagnostic sensitivity of mycobacterial cultures compared to standard voided urine samples, which are often subject to dilution and intermittent shedding of the bacilli.

At Chughtai Lab, the processing of a DJ stent for AFB C/S utilizes state-of-the-art automated liquid culture systems alongside traditional solid media. This dual-method approach ensures the highest possible diagnostic yield. By isolating the Mycobacterium tuberculosis complex from the stent biofilm, clinical microbiologists can not only confirm the diagnosis of GUTB but also perform crucial drug susceptibility testing (DST). This allows urologists and infectious disease specialists to tailor highly specific, effective anti-tuberculous therapy (ATT) regimens, particularly in an era marked by rising drug-resistant tuberculosis strains across Pakistan.

Clinical Procedure: What to Expect

Patient Preparation

Because the specimen for this test is an indwelling medical device, patient preparation focuses primarily on the surgical retrieval of the DJ stent and the strict aseptic handling required to prevent external contamination. Patients must observe the following guidelines:

• Urological Consultation: The removal of a DJ stent is a specialized urological procedure performed via cystoscopy. Patients must follow all pre-operative instructions provided by their urologist, which may include fasting if sedation or general anesthesia is planned.
• Antibiotic Stewardship: Inform your urologist and the Chughtai Lab team of any current or recent antibiotic or anti-tuberculous therapy. Antibiotics can suppress bacterial growth in vitro, potentially leading to false-negative culture results.
• Aseptic Collection: The stent must be removed under strict sterile conditions in an operating theater or cystoscopy suite. It should be placed immediately into a sterile container provided by Chughtai Lab, containing a minimal amount of sterile normal saline to prevent the specimen from drying out.
• Avoid Preservatives: Under no circumstances should the stent be placed in formalin, alcohol, or any other chemical preservative, as these agents kill the mycobacteria, rendering the culture impossible to perform.
• Rapid Transport: The sterile container holding the retrieved stent must be transported to the nearest Chughtai Lab diagnostic center immediately. If a delay is unavoidable, the specimen should be refrigerated at 2°C to 8°C, but it must never be frozen.

During the Procedure

The diagnostic process is divided into two distinct phases: the clinical retrieval of the stent and the subsequent laboratory analysis at Chughtai Lab.

• Stent Retrieval (Cystoscopy): The patient is positioned on a cystoscopy table. Under local, regional, or general anesthesia, the urologist inserts a cystoscope through the urethra into the urinary bladder. Using specialized grasping forceps, the urologist locates the distal loop of the DJ stent, gently withdraws it through the urethra, and immediately transfers it into a sterile specimen container.
• Laboratory Processing: Upon arrival at Chughtai Lab’s specialized microbiology department, the specimen is handled within a Class II Biosafety Cabinet to ensure laboratory safety and prevent contamination.
• Biofilm Dislodgement: The laboratory team subjects the stent to controlled mechanical agitation, vortexing, or mild sonication in sterile saline. This process effectively dislodges the adherent mycobacterial biofilm from both the inner lumen and outer surface of the stent.
• Decontamination and Concentration: The fluid containing the dislodged biofilm undergoes a standardized decontamination process (typically using the N-acetyl-L-cysteine-sodium hydroxide, or NALC-NaOH method). This step eliminates rapidly growing non-mycobacterial flora while preserving the robust, acid-fast mycobacteria. The sample is then centrifuged to concentrate the bacilli.
• Inoculation and Incubation: The concentrated sediment is inoculated into automated liquid culture bottles (such as the BACTEC MGIT system) and onto solid Lowenstein-Jensen (LJ) medium slants. The liquid culture system continuously monitors for fluorescence, which indicates mycobacterial growth, while solid media are inspected weekly for characteristic colonies.

When is an AFB C/S (DJ Stent for Mycobacterium Tuberculosis) Performed?

Investigation of Chronic Sterile Pyuria

Sterile pyuria—the persistent presence of white blood cells in the urine in the absence of bacterial growth on standard culture media—is a classic clinical hallmark of genitourinary tuberculosis. When a patient with a history of chronic urinary tract symptoms presents with sterile pyuria and has an indwelling DJ stent, culturing the stent biofilm for AFB is highly indicated. It helps clinicians differentiate between non-infectious inflammatory conditions and an active, slow-growing mycobacterial infection of the renal parenchyma or ureters.

Evaluation of Unexplained Ureteral Strictures

Ureteral strictures are a common complication of urogenital tuberculosis, resulting from the intense inflammatory response, granuloma formation, and subsequent fibrotic healing within the ureteral walls. If a patient requires a DJ stent to bypass a stricture of unknown etiology, culturing the stent upon its removal is vital. This investigation helps determine if the stricture was caused by active tuberculosis, allowing for timely initiation of anti-tuberculous therapy to prevent further stricture formation and preserve renal function.

Diagnostic Workup for Non-Healing Renal Lesions

In patients presenting with atypical renal masses, cavitary lesions, parenchymal calcifications, or unexplained hydronephrosis on imaging, GUTB must be considered in the differential diagnosis. If these patients have undergone previous urological interventions requiring stent placement, testing the retrieved DJ stent for AFB C/S provides a direct, highly localized microbiological assessment of the upper urinary tract, bypassing the diagnostic limitations of routine blood and urine tests.

Management of Refractory Lower Urinary Tract Symptoms (LUTS)

Patients suffering from severe, progressive lower urinary tract symptoms—such as extreme urinary frequency, urgency, dysuria, and hematuria—that fail to respond to standard broad-spectrum antibiotic regimens are prime candidates for this test. When these patients have an indwelling stent, the device acts as a continuous collector of shedding pathogens. Culturing the stent biofilm allows for the isolation of *Mycobacterium tuberculosis* that may otherwise remain undetected in standard voided urine cultures due to low bacterial loads.

Post-Surgical Surveillance in High-Risk Patients

Patients with a known history of pulmonary tuberculosis, systemic tuberculosis, or those who are immunocompromised (such as patients with HIV, diabetes, or those on immunosuppressive therapy) who undergo urological surgeries involving stent placement require vigilant surveillance. Culturing the retrieved DJ stent for AFB C/S serves as a proactive diagnostic measure to rule out secondary tuberculous seeding of the urinary tract, ensuring that subclinical infections are identified and treated before causing extensive tissue destruction.

What Does an AFB C/S (DJ Stent for Mycobacterium Tuberculosis) Detect?

The AFB C/S on a DJ stent is a comprehensive microbiological evaluation that provides critical insights into the presence, viability, and drug resistance profile of mycobacteria. Specifically, this test detects and evaluates:

• Presence of Acid-Fast Bacilli (AFB) via initial smear microscopy (using Ziehl-Neelsen or fluorochrome staining).
• Growth of the Mycobacterium tuberculosis complex (MTBC) in automated liquid culture media.
• Growth of Mycobacterium tuberculosis on solid Lowenstein-Jensen (LJ) medium.
• Presence of Non-Tuberculous Mycobacteria (NTM) that may colonize the urinary tract or indwelling devices.
• Time to detection (TTD) in liquid culture, which correlates with the bacterial load on the stent.
• Susceptibility of the isolated strain to primary (first-line) anti-tuberculous drugs, including Isoniazid (INH).
• Susceptibility of the isolated strain to Rifampicin (RIF).
• Susceptibility of the isolated strain to Ethambutol (EMB).
• Susceptibility of the isolated strain to Pyrazinamide (PZA).
• Resistance patterns indicating Multidrug-Resistant Tuberculosis (MDR-TB), defined as resistance to at least INH and RIF.
• Resistance to second-line injectable anti-tuberculous drugs (e.g., Amikacin, Kanamycin, Capreomycin) if drug resistance is suspected.
• Resistance to fluoroquinolones (e.g., Levofloxacin, Moxifloxacin) to guide alternative treatment regimens.
• Colony morphology on solid media, helping differentiate MTBC from other mycobacterial species.
• Presence of secondary bacterial pathogens forming co-biofilms on the DJ stent surface.
• Contamination of the specimen by rapid-growing environmental or skin bacteria, indicating collection or transport issues.
• Viability of mycobacteria following a course of anti-tuberculous treatment (to assess treatment efficacy).
• Biofilm-associated bacterial load, reflecting the severity of local colonization.
• Acid-fastness characteristics of the isolated organism under microscopic examination.
• Inhibition of growth by specific mycobacterial inhibitors, confirming the species identity.
• Presence of atypical mycobacterial strains that may require non-standard therapeutic approaches.

Turnaround Time and Report Access at Chughtai Lab

Because *Mycobacterium tuberculosis* is an extremely slow-growing organism, mycobacterial cultures require extended incubation periods compared to routine bacterial cultures. At Chughtai Lab, liquid cultures are monitored continuously for up to 6 weeks (42 days), and solid cultures are maintained for up to 8 weeks before being declared definitively negative. However, positive results are reported immediately upon detection, which can occur as early as 1 to 3 weeks depending on the bacterial load within the stent biofilm.

Chughtai Lab ensures that patients and referring physicians have rapid, seamless access to diagnostic reports. Once a stage of the test is complete (such as the initial smear microscopy or preliminary culture growth), results are uploaded in real-time. Patients receive an SMS notification with a direct link to download their report. Reports can also be accessed online via the official Chughtai Lab website portal or through the user-friendly Chughtai Lab Mobile App. Physical copies of the reports can be collected from any of Chughtai Lab’s numerous collection centers located across Lahore, Karachi, Islamabad, and other major cities nationwide.

AFB C/S (DJ Stent for Mycobacterium Tuberculosis) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Smear Microscopy (ZN Staining)	No Acid-Fast Bacilli (AFB) observed.	Presence of Acid-Fast Bacilli, suggesting active mycobacterial infection.
Liquid Culture (BACTEC MGIT)	No growth of mycobacteria after 42 days of incubation.	Growth of Mycobacterium tuberculosis complex or NTM detected.
Solid Culture (LJ Medium)	No growth of mycobacteria after 8 weeks of incubation.	Rough, buff, non-pigmented colonies characteristic of M. tuberculosis.
First-Line Drug Susceptibility (DST)	Not applicable (only performed if culture is positive).	Resistance detected to Isoniazid, Rifampicin, Ethambutol, or Pyrazinamide.
Second-Line Drug Susceptibility (DST)	Not applicable (only performed for drug-resistant strains).	Resistance to fluoroquinolones or second-line injectable agents.
Stent Biofilm Analysis	No pathogenic biofilm or bacterial colonization detected.	Dense biofilm containing viable, replicating Mycobacterium tuberculosis.
Contamination Control	No growth of environmental or rapid-growing non-acid-fast bacteria.	Overgrowth of contaminant bacteria, potentially compromising the mycobacterial culture.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for AFB C/S (DJ Stent for Mycobacterium Tuberculosis)?

• Advanced Automated Systems: Chughtai Lab utilizes state-of-the-art automated liquid culture technology, ensuring faster detection times and higher sensitivity for mycobacterial isolation.
• ISO 15189 Certified Processes: Our laboratories adhere to strict international quality management standards, ensuring the highest level of accuracy and reliability in clinical microbiology.
• Expert Clinical Microbiologists: All AFB cultures and drug susceptibility tests are supervised and interpreted by highly qualified, experienced consultant microbiologists and pathologists.
• Strict Cold-Chain Maintenance: We employ rigorous sample transport protocols to ensure that retrieved DJ stents are transported under optimal temperature conditions, preserving pathogen viability.
• Comprehensive Drug Susceptibility Testing: Chughtai Lab offers extensive first-line and second-line drug susceptibility testing to guide precise, individualized anti-tuberculous therapy.
• Seamless Digital Report Access: Patients can easily view, download, and share their diagnostic reports via the Chughtai Lab Mobile App, online portal, or secure SMS links.
• Nationwide Diagnostic Network: With hundreds of collection centers across Pakistan, Chughtai Lab provides unmatched accessibility for patients and healthcare providers.
• Dedicated Patient Care: We are committed to providing a compassionate, professional, and patient-focused diagnostic experience from sample submission to final reporting.